Back to top of page

Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (UT1/UT2 Clinical Trial Optional)

- Name and contact information of the applicant/small business concern

- Description of the therapeutic candidate for the treatment of alcohol use disorder (AUD) and/or alcohol associated organ damage (AAOD)

- Background data on the therapeutic candidate in the basic science and early discovery phases

- Evidence of sufficient bioactivity, stability, manufacturability, bioavailability, in vivo efficacy, and target engagement of the therapeutic candidate

- Stage of drug development continuum at which the project will be undertaken

- Proof of desired pharmacological activity for small molecule compounds or profiling of promising product candidates in animal models of AUD or AAOD for biologics

- Proposed milestones and objectives for advancing the molecules closer to U.S. Food and Drug Administration (FDA) approval

- Optional inclusion of early-phase clinical trials in the project proposal

- Women-owned and Small Disadvantaged small business certification, if applicable

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows